FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer
Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp, Rinaldetti, Sebastien, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2018) FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer. BJU International 123 (1), pp. 187-196.Date of publication of this fulltext: 03 Sep 2021 10:09
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | BJU International | ||||
| Publisher: | Wiley | ||||
|---|---|---|---|---|---|
| Place of Publication: | HOBOKEN | ||||
| Volume: | 123 | ||||
| Number of Issue or Book Chapter: | 1 | ||||
| Page Range: | pp. 187-196 | ||||
| Date | 2018 | ||||
| Institutions | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | UROTHELIAL CARCINOMA; TRANSCRIPTION FACTOR; MEDIATES RESISTANCE; RISK STRATIFICATION; MOLECULAR SUBTYPES; EXPRESSION; RECURRENCE; PROGRESSION; VALIDATION; GUIDELINES; FOXM1; non-muscle-invasive bladder cancer; pT1; prognosis; instillation therapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 49205 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric